洞察阿斯巴拉基纳斯过敏反应:探索药物遗传影响
Daiane Keller Cecconello1,2, Klerize Anecely de Souza Silva1,2, Evelin Cristine Mendonça de Senna3
1Post Graduate Program in Child and Adolescent Health, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-003, RS, Brazil.
Pharmaceutics
|September 28, 2024
概括
药物遗传学可以预测儿童急性淋巴细胞白血病 (ALL) 中对阿斯巴拉金酶 (ASNase) 的过敏性. 识别基因变异有助于量身定制治疗方法,并改善全球所有患者的治疗结果.
科学领域:
- 药物基因组学 药物基因组学
- 儿科瘤学 儿科瘤学
- 临床药理学 临床药理学
背景情况:
- 急性淋巴细胞白血病 (ALL) 是最常见的儿童癌症.
- 化疗改善了结果,但发达国家和发展中国家之间存在重大差异.
- 遗传变异性会影响ALL的药物反应和治疗结果.
研究的目的:
- 审查阿斯巴拉金酶 (ASNase) 治疗ALL的药物遗传学的进展.
- 探索单核酸变异 (SNV) 在预测ASNase相关过敏反应中的作用.
- 突出与过敏相关的关键基因,并确定研究差距.
主要方法:
- 对ALL治疗中ASNase的药物遗传研究的文献综述.
- 对已识别的单核酸变异 (SNVs) 和它们与过敏性相关性的分析.
- 专注于像GRIA1,NFATC2,CNTO3,ARHGAP28,MYBBP1A和HLA这样的基因.
主要成果:
- 药物遗传学研究旨在识别SNV,以预测药物反应和不良影响.
- 像GRIA1,NFATC2和HLA这样的基因中的几个SNV与对ASNase的过敏性有关.
- 大多数研究都集中在*大肠杆菌*衍生ASNase上,表明需要对其他配方进行研究.
结论:
- 药物遗传标记可以潜在地预测对ASNase的过敏性,从而实现个性化治疗策略.
- 需要进一步的研究来探索不同ASNase配方中的SNV,以优化ALL治疗.
- 了解ASNase药物遗传学对于减少治疗差异和改善全球患者的治疗结果至关重要.
相关概念视频
Factors Affecting Protein-Drug Binding: Patient-Related Factors
45
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
45
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
102
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
102
Factors Affecting Protein-Drug Binding: Drug Interactions
112
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
112
Allergic Drug Reactions
818
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
818
Nonlinear Pharmacokinetics: Role of Transporters
40
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
40
Nonlinear Pharmacokinetics: Causes of Nonlinearity
144
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
144


